Skip to content

KALA BIO, Inc.

KALA · XNAS

CIK 1479419fmd_06MFA5D2SXXN26D611Z6AHV52DManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2015 to Jun 30, 2026, 43 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading